Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Using mHealth to Help Black Adults in the Midwest With Opioid/Stimulant Use and Mood Symptoms

Official title: Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City

Run by Washington University School of Medicine · NCT07673380 · Data updated 2026-11-12

This study tests a mobile health program to support recovery and mood in Black adults who use opioids or stimulants and are seeking treatment.

More Opioid Use trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedAugust 31, 2025
Main results expectedDecember 31, 2026
Study endsFebruary 28, 2027
Registry record updatedJune 29, 2026
Trial IDNCT07673380 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Black adults (18+) in the U.S. with a history of opioid and/or stimulant use who are seeking treatment and can use English.

Probably not a fit

Participants not experiencing benefit may include those who do not engage with the mHealth tools or who have mood symptoms unlikely to respond to the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional trial compares recovery and engagement outcomes among Black adults who have used opioids or stimulants and are receiving treatment. Participants are randomized to either the original mHealth recovery program (uMAT-R) or the same program with enhanced community engagement. Recruitment occurs through local substance use treatment facilities and recovery services in a Midwestern city. The study aims to see if adding community engagement improves engagement with the mHealth tools and recovery outcomes. English-speaking adults who are U.S. residents are eligible, while those with cognitive impairment are excluded.

Why it matters

Potential benefit: If successful, the intervention could improve engagement with recovery tools and support mood symptoms for Black adults in substance use treatment.

How similar studies have gone: Previous work has shown mHealth tools can support recovery in diverse populations, with added community engagement potentially enhancing impact.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have a history of opioid and/or stimulant use
* Identify as Black and/or African American
* Seek treatment at local substance use treatment centers
* Fluent in English
* U.S. resident
* 18 years of age or older at the time of data collection.

Exclusion Criteria:

* Self-reported cognitive impairment that would limit ability to participate in research.

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.